Abstract-The dopaminergic and renin-angiotensin systems interact to regulate blood pressure. Because this interaction may be perturbed in genetic hypertension, we studied D 1 dopamine and AT 1 angiotensin receptors in immortalized renal proximal tubule (RPT) and A10 aortic vascular smooth muscle cells. Whereas the D 1 -like receptors couple to the stimulatory G protein, G␣ S and thus, activate adenylyl cyclases, the receptors of the D 2 -like subfamily couple to the inhibitory G protein, G␣ i /G␣ O and inhibit adenylyl cyclases and calcium channels and modulate potassium channels. [1] [2] [3] Under euvolemic conditions and magnified during moderate volume expansion, dopamine, through D 1 -like and D 3 receptors, acts to increase sodium excretion and decrease blood pressure. 1, 4, 5 The renin-angiotensin system is another important regulator of sodium transport and blood pressure. 6 Like dopamine, angiotensin exerts its action through several receptor subtypes. AT 1 receptors are linked to Gq/11 and G␣ i /G␣ O , whereas AT 2 receptors are linked to G␣ i 2/3 2,7 ; the G protein linkage of AT 4 receptors is not clear. 8 Although angiotensin, through AT 2 and AT 4 receptors, can decrease blood pressure by vasodilation and increase in sodium excretion, the major effect of angiotensin II is increasing sodium reabsorption and blood pressure, counteracting the effect of dopamine. 6 -10 Dopamine and angiotensin receptors counteract each other in the paracrine regulation of renal sodium transport. Thus, the natriuretic effect of D 1 -like receptors is enhanced when angiotensin II production is decreased or when AT 1 receptors are blocked. 11 Dopamine, through D 1 -like and D 2 -like receptors, by themselves or in concert, antagonizes the stimulatory actions of angiotensin II on proximal tubular luminal sodium transport. Dopamine, through D 1 -like receptors, also decreases AT 1 receptor expression and angiotensin II binding sites in renal proximal tubules. 12-15 D 2 -like receptors, 14 and more specifically, the D 3 receptor, also decrease AT 1 receptor expression in immortalized renal proximal tubule (RPT) cells from normotensive Wistar-Kyoto (WKY) rats. 16 Immortal-
D
opamine, a neurotransmitter in neural tissue, acts as an autocrine/paracrine substance in nonneural tissues. Dopamine produced in neural and nonneural tissues is now recognized to serve an important role in the regulation of blood pressure and sodium balance by direct actions on renal and intestinal epithelial ion transport, by interaction with other receptors, by modulation of the secretion of hormonal/ humoral agents such as aldosterone, catecholamines, renin, and vasopressin, and by actions on brain appetite centers. 1 Dopamine receptors are classified into D 1 -like (D 1 , D 5 ) and D 2 -like (D 2 , D 3 and D 4 ) subtypes, based on their structure and pharmacology. Whereas the D 1 -like receptors couple to the stimulatory G protein, G␣ S and thus, activate adenylyl cyclases, the receptors of the D 2 -like subfamily couple to the inhibitory G protein, G␣ i /G␣ O and inhibit adenylyl cyclases and calcium channels and modulate potassium channels. [1] [2] [3] Under euvolemic conditions and magnified during moderate volume expansion, dopamine, through D 1 -like and D 3 receptors, acts to increase sodium excretion and decrease blood pressure. 1, 4, 5 The renin-angiotensin system is another important regulator of sodium transport and blood pressure. 6 Like dopamine, angiotensin exerts its action through several receptor subtypes. AT 1 receptors are linked to Gq/11 and G␣ i /G␣ O , whereas AT 2 receptors are linked to G␣ i 2/3 2, 7 ; the G protein linkage of AT 4 receptors is not clear. 8 Although angiotensin, through AT 2 and AT 4 receptors, can decrease blood pressure by vasodilation and increase in sodium excretion, the major effect of angiotensin II is increasing sodium reabsorption and blood pressure, counteracting the effect of dopamine. 6 -10 Dopamine and angiotensin receptors counteract each other in the paracrine regulation of renal sodium transport. Thus, the natriuretic effect of D 1 -like receptors is enhanced when angiotensin II production is decreased or when AT 1 receptors are blocked. 11 Dopamine, through D 1 -like and D 2 -like receptors, by themselves or in concert, antagonizes the stimulatory actions of angiotensin II on proximal tubular luminal sodium transport. Dopamine, through D 1 -like receptors, also decreases AT 1 receptor expression and angiotensin II binding sites in renal proximal tubules. 12-15 D 2 -like receptors, 14 and more specifically, the D 3 receptor, also decrease AT 1 receptor expression in immortalized renal proximal tubule (RPT) cells from normotensive Wistar-Kyoto (WKY) rats. 16 Immortal-ized RPT cells have characteristics similar to freshly obtained RPTs and renal brush border membranes. [17] [18] [19] [20] Similar to the counterregulatory effects of these systems on renal sodium transport, the renal vasoconstrictor effect of angiotensin II is counteracted by the vasodilator action of dopamine, through D 1 -like receptors, in normotensive WKY rats. 21, 22 In spontaneously hypertensive rats (SHR), the renal vasodilatory effect of D 1 -like receptors is decreased and there is a lack of D 1 -like receptor antagonism of the vasoconstrictor effect of angiotensin II. 21, 22 Our previous study showed that angiotensin II increases D 1 receptor expression in RPT cells from WKY rats but not from SHR. 23 We hypothesize that there is a differential interaction of D 1 
Methods

Cell Culture
Immortalized RPT cells from WKY and SHR and primary cultures of embryonic thoracic aortic smooth muscle cells (A10) (passage 10 to 20) from normotensive Berlin-Druckrey IX (BD IX) rats were cultured at 37°C in 95% air/5% CO 2 atmosphere in DMEM/F-12 or DMEM, respectively. 17, 24, 25 The cells (80% confluence) were extracted in ice-cold lysis buffer, 17 sonicated, kept on ice for 1 hour, and centrifuged at 16 000g for 30 minutes. The supernatants were stored at Ϫ70°C until use.
Immunoblotting
The antibodies are polyclonal, purified antipeptides. The human AT 1 receptor immunogenic peptide is QDDCPKAGRHC, amino acids 15 to 24 of the AT 1 receptor. The rat D 1 receptor antibody corresponds to positions 299 to 307 (GSEETQPFC) of the D 1 receptor. The specificities of these antibodies have been reported. 17-19,26 -30 The cells were treated with vehicle (dH 2 O), fenoldopam, or a D 1 -like receptor antagonist (SCH23390) at the indicated concentrations and times. Immunoblotting was performed as reported [17] [18] [19] [20] 26 except that the transblots were probed with the D 1 (1:800) or the AT 1 receptor antibody (1:400). Equality of total amount of protein per sample (50 g) transferred onto the membranes was ascertained by Ponceau-S staining and by immunoblotting for ␣-actin.
Immunoprecipitation
RPT cells were incubated with vehicle or fenoldopam (10 Ϫ7 mol/L) for 24 hours, as described above. The cells were lysed with ice-cold lysis buffer for 1 hour and centrifuged at 16 000g for 30 minutes. Supernatant (500 g protein/mL) was incubated with affinitypurified rabbit anti-rat D 1 receptor antibody (2 L/mL) for 1 hour and protein-G agarose at 4°C for 12 hours. The immunoprecipitates were pelleted and washed 4 times with lysis buffer. The pellets were suspended in sample buffer, boiled for 10 minutes, and subjected to immunoblotting with the AT 1 receptor antibody. To determine the specificity of the bands, preimmune serum of D 1 receptor antibody (negative control) and AT 1 receptor antibody (positive control) were used as immunoprecipitants instead of the D 1 receptor antibody. The bands were quantified by densitometry. [17] [18] [19] [20] 26 
Materials
Rabbit anti-human AT 1 receptor antibodies were purchased from Santa Cruz Biotechnology, Inc; D 1 receptor antibodies were customproduced (Research Genetics). Fenoldopam and SCH23390 were from Sigma. A10 cells were from ATCC. Other reagents were of the highest purity available (Sigma or Gibco).
Statistical Analysis
The data are expressed as meanϮSEM. Comparisons within and among groups were made by repeated-measures and factorial ANOVA, respectively, with the Duncan test. A value of PϽ0.05 was considered significant. 
Results
Fenoldopam
Discussion
There are several novel observations in our study. First Both dopamine and renin-angiotensin systems exist in the RPT. 1, 3, 6, 13 The components of the renin-angiotensin system, including angiotensinogen mRNA, renin, and ACE, have been localized the proximal tubule. 6, 13, 31, 32 The proximal tubule is also the site of local dopamine production. 1, 33 Urinary dopamine and angiotensin II concentrations exceed circulating levels, suggesting that both systems may modulate RPT function in an autocrine or paracrine function. 6, 13, 31, [33] [34] [35] Dopamine and angiotensin II are two important regulators of sodium and water absorption in the kidney serving counteracting functions in the proximal tubule. Low concentrations of angiotensin II stimulate net reabsorption through activation of Na ϩ /H ϩ exchanger-3, Na ϩ -HCO 3 cotransporter, and Na ϩ -K ϩ ATPase, 6,12-14,36,37 whereas dopamine exerts the opposite effect. 1, 3, 14, 19, [37] [38] [39] [40] [41] Salt depletion increases angiotensin II production and AT 1 receptor expression in renal proximal tubules in normotensive rats, resulting in increased reabsorption of sodium and water. 6, 13 Conversely, sodium loading increases the production of dopamine, which by activation of D 1 -and D 2 -like receptors, promotes renal sodium and water excretion. 1, 3, 33, 34 The current study shows that long-term D 1 -like receptor stimulation (hours) increases D 1 receptors and decreases AT 1 receptors both in RPT from WKY rats 17 and in A10 vascular smooth muscle cells from normotensive BD IX rats. 24 This may be a mechanism by which D 1 -like receptors continue to exert their effects long after D 1 receptor desensitization should have occurred. [42] [43] [44] The inhibitory effect of the D 1 -like receptor on sodium transport has been consistent, 1, 3, 14, 19, [37] [38] [39] [40] [41] whereas its effect on resistance vessels has not been so. 1 Thus, although most studies have reported a vasorelaxant effect of D 1 -like receptors, 1,3,42 a vasoconstriction effect has been reported in the rat tail artery. 45 In our study, we found that fenoldopam increased D 1 receptor expression in A10 cells but decreased AT 1 receptor expression. These effects together with a D 1 -like receptor-induced increase in cAMP levels should lead to vasodilation in resistance vessels, at least in the normotensive state.
We 48 It is known that the D 1 -like receptor function is impaired in the renal proximal tubule and medullary thick ascending limb of genetically hypertensive rats, such as the SHR. In mesangial, renal proximal tubular, vascular smooth muscle, and adrenocortical cells, increasing intracellular cAMP levels decreases steady state AT 1 receptor expression. 11, 13, [51] [52] [53] Since the 5Ј promoter region of rat AT 1 receptor expression has a cAMP response element, further studies will be required to determine whether cAMP decreases receptor expression by transcriptional and/or posttranscriptional mechanisms. We have reported that D 1 -like receptors can inhibit NHE3 activity independent of cAMP, through G␣S. 19 The linkage between D 1 and D 5 
Perspectives
The dopaminergic and renin-angiotensin systems are two important systems that regulate blood pressure. Dopamine causes natriuresis and vasorelaxation, whereas angiotensin II leads to opposite effects. 1,3-6,12-14,19,36 -41 The major D 1 -like receptor subtype mediating the increase in sodium excretion is probably the D 1 receptor, 1,3,50 whereas the major angiotensin II receptor mediating the decrease in renal sodium excretion is the AT 1 receptor. 6 -10 In SHR, renal proximal tubular D 1 receptor function is impaired. 4 It is possible that the increased renal vascular resistance and increased renal sodium transport in SHR 6, 37, 55 are caused by a defective interaction between D 1 and AT 1 receptors. However, which is primary and which is secondary remains to be determined.
